Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123367464 | 12336746 | 4 | F | 2015 | 20160526 | 20160505 | 20160819 | PER | US-UCBSA-2015040955 | UCB | 0.00 | F | Y | 0.00000 | 20160820 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123367464 | 12336746 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 4 WEEKS | U | 900352/901291 | 125160 | 400 | MG | SOLUTION FOR INJECTION | |||||
| 123367464 | 12336746 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | U | 125160 | SOLUTION FOR INJECTION | ||||||||||
| 123367464 | 12336746 | 3 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | U | 125160 | SOLUTION FOR INJECTION | ||||||||||
| 123367464 | 12336746 | 4 | C | RESTASIS | CYCLOSPORINE | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 5 | C | Calcium | CALCIUM | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 7 | C | FORTEO | TERIPARATIDE | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 8 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 9 | C | Magnesium | MAGNESIUM | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 10 | C | NAPROXEN. | NAPROXEN | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 11 | C | PREDNISONE. | PREDNISONE | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 12 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 13 | C | Potassium | POTASSIUM | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 14 | C | Valsartan + hidroclorotiazida | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 15 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 16 | C | VITAMIN C | ASCORBIC ACID | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 18 | C | XANAX | ALPRAZOLAM | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 19 | C | METOPROLOL. | METOPROLOL | 1 | U | U | 0 | ||||||||||
| 123367464 | 12336746 | 20 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123367464 | 12336746 | 1 | Rheumatoid arthritis |
| 123367464 | 12336746 | 2 | Essential hypertension |
| 123367464 | 12336746 | 3 | Off label use |
| 123367464 | 12336746 | 4 | Product used for unknown indication |
| 123367464 | 12336746 | 5 | Product used for unknown indication |
| 123367464 | 12336746 | 6 | Product used for unknown indication |
| 123367464 | 12336746 | 7 | Product used for unknown indication |
| 123367464 | 12336746 | 8 | Product used for unknown indication |
| 123367464 | 12336746 | 9 | Product used for unknown indication |
| 123367464 | 12336746 | 10 | Product used for unknown indication |
| 123367464 | 12336746 | 11 | Product used for unknown indication |
| 123367464 | 12336746 | 12 | Product used for unknown indication |
| 123367464 | 12336746 | 13 | Product used for unknown indication |
| 123367464 | 12336746 | 14 | Product used for unknown indication |
| 123367464 | 12336746 | 15 | Product used for unknown indication |
| 123367464 | 12336746 | 16 | Product used for unknown indication |
| 123367464 | 12336746 | 17 | Product used for unknown indication |
| 123367464 | 12336746 | 18 | Product used for unknown indication |
| 123367464 | 12336746 | 19 | Product used for unknown indication |
| 123367464 | 12336746 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123367464 | 12336746 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123367464 | 12336746 | Adverse drug reaction | |
| 123367464 | 12336746 | Asthenia | |
| 123367464 | 12336746 | Blood pressure abnormal | |
| 123367464 | 12336746 | Dental caries | |
| 123367464 | 12336746 | Heart rate irregular | |
| 123367464 | 12336746 | Off label use | |
| 123367464 | 12336746 | Rash | |
| 123367464 | 12336746 | Tooth fracture | |
| 123367464 | 12336746 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123367464 | 12336746 | 1 | 201511 | 0 |